IRIS
MANZIA, TOMMASO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.287
EU - Europa 1.376
AS - Asia 1.279
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 7
AF - Africa 4
Totale 21.977
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.275
SG - Singapore 734
CN - Cina 347
IT - Italia 250
IE - Irlanda 247
DE - Germania 235
UA - Ucraina 196
GB - Regno Unito 121
RU - Federazione Russa 106
KR - Corea 102
FI - Finlandia 56
SE - Svezia 51
FR - Francia 38
IN - India 24
VN - Vietnam 17
BE - Belgio 16
CZ - Repubblica Ceca 14
BR - Brasile 11
CA - Canada 11
TR - Turchia 11
HK - Hong Kong 10
JP - Giappone 9
EU - Europa 7
GR - Grecia 7
NL - Olanda 7
AU - Australia 6
ES - Italia 6
AT - Austria 4
CH - Svizzera 4
EG - Egitto 4
PL - Polonia 4
TM - Turkmenistan 4
CO - Colombia 3
HR - Croazia 3
IL - Israele 3
IQ - Iraq 3
PT - Portogallo 3
HU - Ungheria 2
ID - Indonesia 2
IR - Iran 2
KH - Cambogia 2
MY - Malesia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
DM - Dominica 1
EC - Ecuador 1
EE - Estonia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MV - Maldive 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RO - Romania 1
TW - Taiwan 1
Totale 21.977
Salva come PNG Salva come JPEG
Città #
Wilmington 5.354
Houston 4.909
Woodbridge 4.298
Fairfield 796
Singapore 659
Ann Arbor 472
Chandler 460
Ashburn 339
Seattle 306
Cambridge 287
Dublin 236
Santa Clara 190
Medford 184
Jacksonville 168
Beijing 124
New York 114
Zhengzhou 101
Lawrence 86
Rome 86
Dearborn 73
San Diego 50
Creede 45
Moscow 45
Menlo Park 34
Mülheim 28
London 25
Palo Alto 24
Shanghai 21
Los Angeles 20
Nanjing 19
Mountain View 18
Boardman 17
Redwood City 17
Milan 16
Norwalk 16
Brussels 15
Seoul 15
Dong Ket 14
Hefei 13
Helsinki 13
Council Bluffs 12
Engelhard 12
Toronto 11
Hounslow 9
Olomouc 9
Islington 8
Saint Petersburg 8
University Park 8
Aydin 7
Guangzhou 7
Kunming 7
Nanchang 7
Nürnberg 7
San Mateo 7
Verona 7
Civita Castellana 6
Colorado Springs 6
Falls Church 6
Genoa 6
Hong Kong 6
Lappeenranta 6
Munich 6
New Bedfont 6
Pune 6
São Paulo 6
Turin 6
Brno 5
Chicago 5
Miami 5
Shenyang 5
Washington 5
Amsterdam 4
Athens 4
Chiswick 4
Delhi 3
Detroit 3
Eschweiler 3
Esslingen am Neckar 3
Gdynia 3
Hebei 3
Jinan 3
Kilburn 3
Nuremberg 3
Phoenix 3
Sydney 3
Thessaloniki 3
Vienna 3
Xian 3
Yinchuan 3
Zagreb 3
Asaka 2
Augusta 2
Basra 2
Bhubaneswar 2
Brescia 2
Budapest 2
Chateaugiron 2
Chennai 2
Cuttack 2
Enterprise 2
Totale 20.004
Salva come PNG Salva come JPEG
Nome #
Re-Evaluation of the Role of Antifibrinolytic Therapy with Lysine Analogs in Liver Transplantation in The Post-Aprotinin Era 452
HCV-RNA quantification in liver bioptic samples and extrahepatic compartments, using the abbott RealTime HCV assay 446
Impact of immunosuppression minimization and withdrawal in long-term hepatitis C virus liver transplant recipients 443
Primary yolk sac tumor of the liver: incidental finding in a patient transplanted for hepatocellular carcinoma 438
Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: Two case reports 436
Relationship between GH/IGF-1 Axis, graft recovery, and early survival in patients undergoing liver transplantation 432
Deep vein thrombosis as debut of cytomegalovirus infection associated with type ii cryoglobulinemia, with antierythrocyte specificity in a kidney transplant recipient: A case report 432
Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation. 423
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. 420
Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis. 418
Marginal donors in liver transplantation. 416
Liver abscess caused by foreign body ingestion 409
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting. 408
596 402
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 402
Management of spermatic cord liposarcoma in renal transplant recipients: case report 401
Use of mycophenolate mofetil in liver transplantation: a literature review. 398
Complete hbv prophylaxis withdrawal in HBsAg-positive liver transplant recipients after long-term minimal immunosuppression 395
Ab initio calcineurin inhibitor-based monotherapy immunosuppression after liver transplantation reduces the risk for Pneumocystis jirovecii pneumonia. 392
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. 388
Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C 387
Liver transplantation in primary hepatic carcinoid tumor: case report and literature review. 384
The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up 383
Surgical antibiotic prophylaxis after renal transplantation: time to reconsider. 379
Liver transplantation for the treatment of nodular regenerative hyperplasia 379
Side-to-side caval anastomosis in a patient receiving a liver graft from a marginal donor with situs inversus totalis 378
Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting 376
Different expression of VEGF and EGFL7 in human hepatocellular carcinoma 372
Immunosuppression-Free Liver Transplantation 369
Radiofrequency-assisted right hemihepatectomy by using a new incremental bipolar generator combined with liver hanging maneuver. 361
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: A randomized, controlled clinical trial 359
Prospect for kidney bioengineering: Shortcomings of the status quo 352
The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. 346
Myopericytoma of the Liver Hilus: A Case Report 341
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. 335
Liver transplantation for hepatitis B and C virus-related cirrhosis: mid-term results 318
Successful management of a same-day emergency delivery and liver transplant in a 27 weeks pregnant woman with fulminant hepatic failure. 316
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 316
Ab initio Everolimus-based Versus Standard Calcineurin Inhibitor Immunosuppression Regimen in Liver Transplant Recipients 303
Clinical Operational Tolerance and Immunosuppression Minimization in Kidney Transplantation: Where Do We Stand? 281
An unusual duodenal polyp causing anemia in a liver-transplanted patient 280
Donation after circulatory death in paediatric liver transplantation: current status and future perspectives in the machine perfusion era 279
Impact of remnant vital tissue after locoregional treatment and liver transplant in hepatocellular cancer patients, a multicentre cohort study 266
Pitfalls in the reporting of upper endoscopy features in cirrhotic patients 260
Liver transplantation with a normothermic machine preserved fatty nonagenarian liver: A case report 254
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 248
Longterm Survival and Cost-Effectiveness of Immunosuppression Withdrawal After Liver Transplantation 240
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 231
Effect of direct-acting antivirals on future occurrence of hepatocellular carcinoma in compensated cirrhotic patients 230
Rare malignant glomus tumor of the stomach with liver metastases 208
Pandora’s Box: Unpredictable Evolution of a 20-Year History of a Bariatric Patient—Report of Small Bowel Migrated Gastric Band after Redo Banded Gastric Bypass 206
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 180
Platelets and hepatocellular cancer: Bridging the bench to the clinics 167
Everolimus and enteric-coated mycophenolate sodium Ab initio after liver transplantation: Midterm results 166
Intention-to-treat survival benefit of liver transplantation in patients with hepatocellular cancer 162
Liver transplantation for hepatocellular carcinoma: Where do we stand? 160
The COVID-19 outbreak in Italy: initial implications for organ transplantation programs 151
Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome 148
Everolimus and Advagraf Ab Initio in Combined Liver and Kidney Transplant With Donor-Specific Antibodies: A Case Report 147
Vascular anomalies of the celiac trunk and implications in treatment of HCC with TACE. Description of a case and review of the literature 143
De novo malignancies after liver transplantation: The effect of immunosuppression-personal data and review of literature 141
Liver transplantation in a patient with complete portal vein thrombosis, is there a surgical way out? A case report 137
Abdominal organ bioengineering: current status and future perspectives 129
Evaluation of Contrast-Enhanced Intraoperative Ultrasound in the Detection and Management of Liver Lesions in Patients with Hepatocellular Carcinoma 129
Using a weaning immunosuppression protocol in liver transplantation recipients with hepatocellular carcinoma: A compromise between the risk of recurrence and the risk of rejection? 125
How do synchronous lung metastases influence the surgical management of children with hepatoblastoma? An update and systematic review of the literature 123
The Intention-to-Treat Effect of Bridging Treatments in the Setting of Milan Criteria–In Patients Waiting for Liver Transplantation 111
Laparoscopic adrenalectomy for hemorrahagic adrenal pseudocyst discovered during pregnancy: Report of a case 110
Screening of Fabry Disease of patients in renal replacement therapy in a population from Lazio (Italy) 98
Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report 90
Serum Levels of Granulocyte-Macrophage-colony-stimulating Factor and Stem-cell Factor During Liver Regeneration after Partial Hepatectomy in Humans 80
Hepatitis B virus recurrence after liver transplantation: An old tale or a clear and present danger? 72
Current strategies to minimize ischemia-reperfusion injury in liver transplantation: a systematic review 51
The hamletic dilemma of patients waiting for kidney transplantation during the COVID-19 pandemic: to accept or not to accept (an organ offer)? 50
High-priority liver transplantation and simultaneous sleeve gastrectomy in MELD 32 end-stage liver disease: a case report with long-term follow-up 47
Graft weight integration in the early allograft dysfunction formula improves the prediction of early graft loss after liver transplantation 43
Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries 39
Liver transplantation performed in a SARS-CoV-2 positive hospitalized recipient using a SARS-CoV-2 infected donor 39
Correction to: Immunosuppressive regimens for adult liver transplant recipients in real-life practice: consensus recommendations from an Italian Working Group (Hepatology International, (2020), 14, 6, (930-943), 10.1007/s12072-020-10091-5) 39
Chronic rejection after liver transplantation: Opening the Pandora's box 37
Moving forward in the treatment of cholangiocarcinoma 36
“Salus Populi Suprema Lex”: Considerations on the Initial Response of the United Kingdom to the SARS-CoV-2 Pandemic 36
Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation 35
Temporal trends of waitlistings for liver transplantation in Italy: the ECALITA (Evolution of IndiCAtion in LIver transplantation in ITAly) registry study 35
Successful clinical and virological outcomes of liver transplantation for HDV/HBV-related disease after long-term discontinuation of hepatitis B immunoglobulins 33
Transarterial chemoembolization of hepatocellular carcinoma before liver transplantation and risk of post-transplant vascular complications: a multicentre observational cohort and propensity score-matched analysis 33
The role of antiplatelet therapies on incidence and mortality of hepatocellular carcinoma 33
Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation 32
A Keynesian perspective on the health economics of kidney transplantation would strengthen the value of the whole organ donation and transplantation service 29
Towards tolerance in liver transplantation 28
Liver transplantation from active COVID-19 donors: a lifesaving opportunity worth grasping? 28
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 28
Sarco-Model: A score to predict the dropout risk in the perspective of organ allocation in patients awaiting liver transplantation 27
Cancer mortality after kidney transplantation: A multicenter cohort study in Italy 27
Proposal and validation of a liver graft discard score for liver transplantation from deceased donors: a multicenter Italian study 27
The liver transplant surgeon Mondays blues: an Italian perspective 27
Outcomes and surgical complications following living-donor renal transplantation using kidneys retrieved with trans-peritoneal or retro-peritoneal hand-assisted laparoscopic nephrectomy 26
Pancreatic Adeno-MiNEN, a Rare Newly Defined Entity with Challenging Diagnosis and Treatment: A Case Report with Systematic Literature Review and Pooled Analysis 26
Global management of a common, underrated surgical task during the COVID-19 pandemic: Gallstone disease - An international survery 26
The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy 26
Totale 21.800
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.679 0 0 0 519 430 533 552 491 630 575 437 512
2020/20214.039 472 487 459 484 391 458 473 454 78 125 95 63
2021/2022933 54 90 16 32 24 95 61 33 123 117 54 234
2022/20231.411 141 123 15 151 112 259 109 256 105 12 93 35
2023/2024691 78 38 81 17 96 163 33 13 20 38 9 105
2024/20251.389 97 771 454 67 0 0 0 0 0 0 0 0
Totale 22.506